In accordance with data from TGCA, BCYRN1 was found to be highly expressed in HCC patients (n = 375) in contrast with normal (n = 50, Fig. 1a, b, P < 0.0001). The gene discussed is BCYRN1; the disease is hepatocellular carcinoma.